Organon & Co saw the highest growth of 0.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Organon & Co’s patent filings and grants. Buy the databook here.
Organon & Co has been focused on protecting inventions in Denmark(DK) with one publication in Q2 2024
The Denmark(DK) Patent Office dominates the patent filings with nearly 50% of filings. The Denmark(DK), South Korea(KR), Finland(FI), and Israel(IL) patent Office are among the top ten patent offices where Organon & Co is filings its patents. Among the top granted patent authorities, Organon & Co has 33% of its grants in Finland(FI), 33% in Israel(IL) and 33% in Portugal(PT).
Roche and Johnson & Johnson could be the strongest competitors for Organon & Co
For comprehensive analysis of Organon & Co's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.